ADPT Adaptive Biotechnologies Corpor
$27.66▲ +5.29%
Healthcare
Other
Pre-market
$27.50▼ -0.58%
Oct 28, 4:10 AM ET
Volume 1.52M
Avg Volume (10D) 1.56M
Key Metrics & Fundamentals
Market Cap
$4.41B
P/E Ratio
–
Div Yield
0.00%
52W Range
12.00 - 30.74
% vs 50 MA
5.47%
% vs 200 MA
42.14%
RSI-14
57.9
MACD Histogram
+0.0900
Beta (1Y vs SPY)
1.65
Free Cash Flow
-$7.58M
Gross Rev
$71.55M
Gross Profit
$51.39M
EBITDA
-$9.82M
COGS
$20.17M
Operating Exp
$67.16M
Operating Income
-$15.77M
EBIT
-$15.77M
Pretax Income
-$39.94M
Net Income
-$39.79M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
Adaptive Biotechnologies Corp. (ADPT) Rallies on Earnings Beat, Raised Outlook, and Cash-Flow Targets
Insider Monkey · Oct 27, 2026 10:54 AM ET
What Happens To Tempus AI Stock If Its Cash Burn Continues?
Trefis · Oct 26, 2026 8:47 AM ET
Adaptive Biotechnologies Insider Sold Shares Worth $879,088, According to a Recent SEC Filing
MT Newswires · Oct 22, 2026 4:59 AM ET
Should You Be Worried About Tempus AI Stock?
Trefis · Oct 20, 2026 7:03 AM ET
Adaptive Biotechnologies Insider Sold Shares Worth $897,356, According to a Recent SEC Filing
MT Newswires · Oct 19, 2026 4:07 AM ET
Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 14, 2026 4:05 PM ET
Could You Have Seen The Run In Tempus AI Stock Coming?
Trefis · Oct 9, 2026 10:19 AM ET
Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism
Simply Wall St. · Oct 8, 2026 4:18 PM ET
Adaptive Biotechnologies Insider Sold Shares Worth $1,014,329, According to a Recent SEC Filing
MT Newswires · Oct 6, 2026 3:25 AM ET
Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update
Simply Wall St. · Sep 25, 2026 5:06 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADPT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.